Neurology

Panelists discuss how various approved and investigational FcRn-targeting agents differ in their mechanisms of action…

Panelists discuss how complement inhibitors work to treat generalized myasthenia gravis (gMG), evaluating their efficacy…

At week 25 of treatment with trontinemab, patients demonstrated decreases in CSF total tau, CSF…

Bruce Leuchter, MD, president and chief executive officer at Neurvati Neurosciences, provided clinical insight on…

Here's some of what is coming soon to NeurologyLive® this week.: Source: Neurology Read More

The senior director of research strategy at Banner Alzheimer’s Institute talked about improving clinical trial…

Amy Tsou, MD, MSc, program director at the National Institutes of Neurological Disorders and Stroke,…

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of…

Over a 24-week period, comprising both the core study and extension trial, the incidence of…

The professor of molecular geriatrics at Uppsala University talked about the research journey that led…